Skip to content
Film Television Auditions – Lifestyle
Author:
Memento Medicines, Inc.
Memento Medicines Launches with $93 Million Series A Financing to advance Tie2 Agonist and VEGF Inhibitor Bispecific Antibody Therapy for Retinal Diseases
June 18, 2026